Drawing for AMYREX

USPTO serial 78160140

AMYREX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SOMERVILLE, ARETHA CHARESE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AMYREX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

J.SCOTT EVANS

J SCOTT EVANS ADAMS, SCHWARTZ & EVANS, PA2180 TWO WACHOVIA CTR301 S TRYON STCHARLOTTE, NC 28282

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations; antibody preparations; monoclonal antibodies; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; proteins; recombinant antibodies; vaccines; all of the above aforesaid goods being for the diagnosis or treatment of amyloidosis.ACTIVE—
042Scientific, medical and industrial research, all relating to amyloidosis; biochemical analysis and biochemical research both relating to amyloidosis; diagnosis of predisposition to amyloidosis; amyloidosis disease management; amyloidosis drug design; amyloidosis health care; prophylaxis and treatment of medical disorders all relating to amyloidosis; vaccination and treatment of amyloidosis patients.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 22, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 17, 2003DOCKASSIGNED TO EXAMINER—
Jan 28, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2003DOCKASSIGNED TO EXAMINER—
Dec 6, 2002MAILPAPER RECEIVED—

Frequently asked questions

Related guidance